Tech Company Financing Transactions
Lever Bio Funding Round
Lever Bio closed a $4.5 million venture capital round on 5/28/2025. Backers included Claris Ventures and private investors.
Transaction Overview
Company Name
Announced On
5/28/2025
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Undisclosed
Investors
Claris Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to further progress the assets through preclinical development and validate their therapeutic potential and positioning in solid tumors.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Via Ettore De Sonnaz 19
Torino, 10121
Italy
Torino, 10121
Italy
Phone
Undisclosed
Website
Email Address
Overview
Lever Bio was launched by Claris Ventures and Exor Ventures, with the aim to collaborate with top researchers to drive innovative drug development programs. The Company was incorporated in 2024 and in the first-half 2025 closed the in-licensing and kicked-off the development of 6 programs in the therapeutic area of immuno-oncology. Our vision is to unlock biotech innovation in immuno-oncology working with researchers, universities and research centers to ultimately improve patient outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pietro Puglisi
Browse more venture capital transactions:
Prev: 5/28/2025: Besample venture capital transaction
Next: 5/28/2025: Javara Research venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs